Table 1.
First author | Publication year | No. enrolled | Age | Male, % | Hypertension, % | Diabetes, % | Chronic renal dysfunction, % | Contrast volume (F/C), ml | Furosemide administration | CIN definition | Jadad score |
---|---|---|---|---|---|---|---|---|---|---|---|
Gu GQ, et al. | 2013 | 859 | 59 | 72 | 72 | 21 | 25.2 | 100/100 | IV, 20 mg before procedure | SCr >25% of baseline, or >0.5 mg/dl, at 48 h post-procedure | 3 |
Majumdar SR, et al. | 2009 | 92 | 65 | 77 | 77 | 37 | 100 | 152/126 | IV drip, 100 mg before procedure | SCr >25% of baseline, or >0.5 mg/dl, at 48 h post-procedure | 5 |
Marenzi G, et al. | 2012 | 170 | 74 | 78 | 83 | 40 | 100 | 181/158 | IV, 0.5 mg/kg before procedure | SCr >25% of baseline, or >0.5 mg/dl, at 72 h post-procedure | 4 |
Shemirani H, et al. | 2012 | 120 | 65 | 51 | – | – | – | 119/133 | Oral | SCr >0.5 mg/dl, at 48 h post-procedure | 3 |
Solomon R, et al. | 1994 | 53 | 65 | 66 | – | 53 | 100 | 132/125 | IV, 80 mg before procedure | SCr >0.5 mg/dl, at 48 h post-procedure | 3 |
CIN – contrast-induced nephropathy; F/C – furosemide/control; IV – intravenous injection; SCr – serum creatinine.